Yahoo
NasdaqCM - Nasdaq Real Time Price USD

Rockwell Medical, Inc. (RMTI)

0.7359 -0.0212 (-2.80%)
As of 3:19:18 PM EDT. Market Open.
Chart Range Bar
Loading chart for RMTI
  • Previous Close 0.7571
  • Open 0.7400
  • Bid 0.5180 x 200
  • Ask 0.9660 x 200
  • Day's Range 0.7340 - 0.7600
  • 52 Week Range 0.7300 - 2.1000
  • Volume 233,413
  • Avg. Volume 260,930
  • Market Cap (intraday) 29.046M
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) -0.1500
  • Earnings Date May 7, 2026
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 3.00

Rockwell Medical, Inc., together with its subsidiaries, engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. It offers citrapure citric acid concentrate, dri-sate dry acid concentrate, renalpure liquid acid concentrate, dri-sate acid concentrate mixer, renalpure acid concentrate, renalpure bicarbonate concentrate, sterilyte bicarbonate concentrate, bicarbonate cartridges, and dry acid concentrate mixer, as well as ancillary products, including 5% acetic acid, cleaner, citric acid descaler, water softener salt pellets, and other supplies used by hemodialysis providers. The company's hemodialysis concentrate products are used to sustain patient's life by removing toxins and balancing electrolytes in a dialysis patient's bloodstream. In addition, it offers dialysis concentrates, dialysis kits, and other ancillary products used in the dialysis process. The company was formerly known as Rockwell Medical Technologies, Inc. and changed its name to Rockwell Medical, Inc. in June 2012. Rockwell Medical, Inc. was incorporated in 1996 and is headquartered in Wixom, Michigan.

www.rockwellmed.com

157

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Performance Overview

Trailing total returns as of 5/29/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

RMTI
11.34%
S&P 500 (^GSPC)
10.77%

1-Year Return

RMTI
21.71%
S&P 500 (^GSPC)
28.25%

3-Year Return

RMTI
69.21%
S&P 500 (^GSPC)
80.30%

5-Year Return

RMTI
92.31%
S&P 500 (^GSPC)
80.36%

Earnings Trends

View More

Earnings Per Share (GAAP)

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q1 FY26
Revenue 17.34M
Earnings --

Q2

FY25

Q3

FY25

Q4

FY25

Q1

FY26

0
5M
10M
15M

Analyst Insights

View More

Analyst Price Targets

2.00
3.00 Average
0.7359 Current
4.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 3/30/2026
Analyst HC Wainwright & Co.
Rating Action Maintains
Rating Buy
Price Action Lowers
Price Target 2.5 -> 2

Statistics

View More

Valuation Measures

Annual
As of 5/28/2026
  • Market Cap

    30.08M

  • Enterprise Value

    20.58M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.42

  • Price/Book (mrq)

    0.84

  • Enterprise Value/Revenue

    0.30

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -7.99%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    67.68M

  • Net Income Avi to Common (ttm)

    -5.56M

  • Diluted EPS (ttm)

    -0.1500

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    33.72%

  • Levered Free Cash Flow (ttm)

    --

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights

Fair Value

0.7359 Current

Dividend Score

0 Low
Sector Avg.
100 High

Hiring Score

0 Low
Sector Avg.
100 High

Insider Sentiment Score

0 Low
Sector Avg.
100 High

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: